(Q24244006)

PubMed

30 October 2023

Dan Turner

1

D

Turner

1 reference

PubMed

17636844

30 October 2023

Anne Marie Griffiths

series ordinal

3

author given names

A M

author last names

Griffiths

1 reference

PubMed

17636844

Cochrane Database of Systematic Reviews

30 October 2023

language of work or name

1 reference

1 September 1996

0 references

published in

0 references

cites work

Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil ω-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

N-3 fatty acids for the treatment of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Assessing the quality of randomized trials: reliability of the Jadad scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Enteral absorption in man of eicosapentaenoic acid in different chemical forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Lipid treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Omega 3 fatty acids for prevention and treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Supressive effect of maslinic acid from pomace olive oil on oxidative stress and cytokine production in stimulated murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

New mediators of immunity and inflammation in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Azathioprine for maintaining remission of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

A Comparison of Oral Prednisolone Given as Single or Multiple Daily Doses for Active Proctocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Omega-3 fatty acids in inflammation and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Essential fatty acid depletion in children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Dietary Supplementation with Fish Oil in Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Cortisone in ulcerative colitis; final report on a therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

A simple clinical colitis activity index

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

Aggregate data meta-analysis with time-to-event outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006443.PUB2

10.1002/14651858.CD006443.PUB2

21 January 2018

Identifiers

DOI

0 references

Fatcat ID

release_tt5q6lgzubao3iodrzv7keiada

0 references